Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Marx, S.
Diener, H. -C. [2 ]
Harenberg, J.
Lip, G. [3 ]
Marder, V. [4 ]
Wehling, M.
Weiss, C. [1 ]
机构：
[1] Univ Heidelberg, Med Fac Mannheim, Dept Biometr & Stat, D-6800 Mannheim, Germany
[2] Univ Clin Essen, Dept Neurol, Essen, Germany
[3] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：815 / 815
页数：1
相关论文
共 50 条
  • [1] Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis
    Marx, Svetlana
    Harenberg, Job
    Wehling, Martin
    Weiss, Christel
    Diener, Hans-Christoph
    Marder, Victor J.
    Lip, Gregory Y. H.
    THROMBOSIS RESEARCH, 2012, 130 : S100 - S101
  • [2] Efficacy and Safety of Dabigatran, Rivaroxaban, and Apixaban Compared to Warfarin in Asian Patients With Non-valvular Atrial Fibrillation: A Systemic Review and Meta-analysis
    Li, Weijia
    Kokkinidis, Damianos
    Wang, Yu Chiang
    CIRCULATION, 2020, 142
  • [3] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [4] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
    Li, Wei-Jia
    Archontakis-Barakakis, Paraschos
    Palaiodimos, Leonidas
    Kalaitzoglou, Dimitrios
    Tzelves, Lazaros
    Manolopoulos, Apostolos
    Wang, Yu-Chiang
    Giannopoulos, Stefanos
    Faillace, Robert
    Kokkinidis, Damianos G.
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (04): : 82 - 94
  • [5] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Ashley Prentice
    Irene Ruiz
    Erin R. Weeda
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 360 - 364
  • [6] Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis
    Harenberg, J.
    Marx, S.
    Diener, H. -C.
    Lip, G. Y. H.
    Marder, V. J.
    Wehling, M.
    Weiss, C.
    INTERNATIONAL ANGIOLOGY, 2012, 31 (04) : 330 - 339
  • [7] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Prentice, Ashley
    Ruiz, Irene
    Weeda, Erin R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (03) : 360 - 364
  • [8] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
  • [9] Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis
    Memon, Rahat A.
    Hamdani, Syed Shah Qasim
    Usama, Ali
    Aisha, F. N. U.
    Kundi, Hayan
    Mathavan, Mohit
    Khalid, Malaika
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [10] Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups
    Lip, Gregory Y. H.
    Mitchell, Stephen A.
    Liu, Xianchen
    Liu, Larry Z.
    Phatak, Hemant
    Kachroo, Sumesh
    Batson, Sarah
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 204 : 88 - 94
12345